Alpha Paradigm Partners »

Akero Therapeutics shares owned by Alpha Paradigm Partners

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Alpha Paradigm Partners from 13F filings

Historical chart of Alpha Paradigm Partners investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Alpha Paradigm Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Alpha Paradigm Partners

Quarter filed Position value Share count Share price at filing
2022-12-31 $716k 13k 54.77

More positions owned by Alpha Paradigm Partners

Alpha Metallurgical Resources (AMR)
Harmonic (HLIT)
Clearfield (CLFD)
Flextronics International Ltd Com Stk (FLEX)
STAAR Surgical Company (STAA)
Amazon (AMZN)
Lamb Weston Hldgs (LW)
salesforce (CRM)
Manchester Utd Plc New Ord Cl (MANU)
Crown Castle Intl (CCI)
Verint Systems (VRNT)
Electronic Arts (EA)
Teekay Tankers Ltd cl a (TNK)
Vertex Pharmaceuticals Incorporated (VRTX)
Arch Capital Group (ACGL)

View all positions for Alpha Paradigm Partners

Top funds holding Akero Therapeutics

Henderson Group
General Atlantic
BlackRock
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Redmile Group
Boxer Capital
Alliancebernstein
Yiheng Capital
Geode Capital Management
Perceptive Advisors
Fred Alger Management
Rock Springs Capital Management

View all funds holding Akero Therapeutics